Sodium Valproate: Health Services
Commons · Question 106956 · Tabled 20 Jan 2026 · Department of Health and Social Care · Official record
Answered 29 Jan 2026
Question
Asked by Bob Blackman
To ask the Secretary of State for Health and Social Care, what guidance exists for Integrated Care Boards on supporting individuals with complex, medicine-induced disabilities arising from sodium valproate.
Answer
Answered by Zubir Ahmed, 29 Jan 2026
The Independent Medicines and Medical Devices Safety Review, First Do No Harm, identified significant shortcomings in National Health Service care pathways for people harmed by sodium valproate, including fragmented services, limited diagnostic expertise,...